SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia shares are under pressure as traders react to the boards investigation into Jensen Huangs admitted affair with a businesswoman reported to have suspected ties to Chinese intelligence, raising concerns about governance, possible information leaks, and Huangs future as CEO. The community is divided between seeing the probe and leadership uncertainty as a serious overhang and treating the controversy as unrelated to Nvidias AI-chip business and a buying opportunity.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is under heavy selling pressure ahead of its Q3 earnings report, with traders speculating about a possible leak while others see the decline as pre-report positioning; a leak is unconfirmed. Bulls point to growth and potential upbeat guidance, while bears worry that the Eli Lilly obesity-drug deal could pressure margins and profitability.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics quarterly revenue beat and higher full-year outlook, driven by BRIUMVI growth, are the main focus; shares saw a sharp post-results dip and recovery, prompting debate over a sell the news reaction versus short-driven volatility. Traders are also watching for Phase 3 results on subcutaneous BRIUMVI as a next potential catalyst.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

IWMs sharp rally is drawing attention as small caps outperform, with traders describing a possible low-volume short squeeze and rotation into the Russell 2000. Bulls are chasing calls and citing hopes for easing inflation, while skeptics question the moves strength given reported weak flows and limited volume.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors pending FDA decision on deramiocel for Duchenne muscular dystrophy, focused on the amended upper-limb-function evidence from HOPE-3, is driving attention ahead of the Nov. 22 PDUFA date. Bulls cite the trial data and a letter urging approval from 28 investigators, while skeptics point to FDA scrutiny and the earlier negative advisory-panel vote on the cardiac indication; short-squeeze speculation adds to the debate.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rally is drawing attention after Oppenheimer upgraded the stock, while Google Clouds use of EPYC processors in its AI infrastructure added a company-specific catalyst. Traders also point to money rotating from Nvidia amid a CEO-related investigation, though some see the move as sentiment-driven and question AMDs valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels SITC findings on immune activation and viral clearance, alongside its positive Phase 3 prostate-cancer results, are drawing attention as the company prepares a BLA for CAN-2409. Bulls see the data as supportive of the regulatory package, while skeptics question filing and manufacturing execution and warn of a possible sell-the-news reaction.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

A quarterly earnings shortfall and reduced full-year revenue guidance, tied largely to federal Dedrone drone deployments being delayed, have driven a sharp selloff. Traders debate whether the decline overreacts to a timing issue or reflects high valuation and weaker near-term growth, with some buying the dip and others expecting further downside.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk shares are rallying sharply ahead of its Q3 earnings report, with traders speculating about short covering and an earnings leak, though neither explanation is confirmed. The move has fueled hopes for a turnaround, while many investors worry that weak results or guidance could erase the gains.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Agility Robotics Inc.

Agility Robotics Inc. - Ordinary Shares - Class A

Post-merger selling in Agility Robotics is drawing attention, with traders pointing to typical de-SPAC volatility and questioning the companys steep losses, limited revenue, and path to commercial scale. Some remain bullish on humanoid robotics and the companys reported orders, but the discussion is dominated by skepticism about valuation and near-term execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stratasys Sets 2030 Environmental Targets and Completes First Climate Risk Analysis Disclosed in Fifth Annual Sustainability Report

Stratasys Ltd. (NASDAQ: SSYS) today released its fifth annual Environmental, Social and Governance (ESG) and Sustainability Report. The report marks the progression of the company's Mindful Manufacturing strategy. It discloses company-wide 2030 environmental and safety targets and reveals the...

Stratasys Introduces New Printer for Serial Production, Alongside F870 European Debut and Factory-Floor Applications from Toyota and GM at Formnext 2026

Stratasys Ltd. (NASDAQ: SSYS) will announce a new manufacturing solution, debut the F870 FDM system in Europe and showcase factory-floor applications from Toyota, GM and other manufacturers at Formnext 2026, November 1720, in Hall 12.1, Booth D129 at Messe Frankfurt. Trusted by Manufacturers...

Stratasys Conference Call to Discuss Third Quarter 2026 Financial Results

Stratasys Ltd. (Nasdaq: SSYS) will release financial results for the third quarter ended September 30, 2026, on Thursday, November 12, 2026. The Company plans to hold the conference call to discuss its third quarter 2026 financial results on Thursday, November 12, 2026, at 8:30 a.m. (ET). The...

Stratasys Announces 2026 Annual General Meeting of Shareholders

Stratasys Ltd. (Nasdaq: SSYS) (Stratasys or the Company) today announced that it will hold its 2026 Annual General Meeting of Shareholders (the Meeting) on Tuesday, November 10, 2026, at 3:00 p.m. Israel time, at Meitar Law Offices, 1 Ariel Sharon Street, 36th floor, Givatayim 5320048, Israel. The...

Top 3D Printing Stocks to Buy for Solid Long-Term Returns

3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like ATI, NVDA, AVNT, PRLB and SNPS offer strong growth potential.

Stratasys Additive Manufacturing Solutions to Roll Out Across 20+ GM Manufacturing Facilities

Stratasys Ltd. (NASDAQ: SSYS) today announced a new showcase of its longstanding collaboration with General Motors (GM), highlighting how one of the world's most advanced manufacturers is leveraging Stratasys additive manufacturing solutions to reduce manufacturing lead times and costs while...

Stratasys Brings Production-Proven Additive Manufacturing to IMTS 2026 Across Aerospace, Defense, Automotive and Healthcare Applications

Stratasys Ltd. (NASDAQ: SSYS) today announced it will showcase production-proven additive manufacturing solutions at the International Manufacturing Technology Show (IMTS) 2026 in Chicago. During the show, from September 14 to 19, Stratasys will demonstrate solutions for manufacturers utilizing...

Toyota and Rivian Adopt Stratasys' New F870 to Accelerate Factory-Floor Manufacturing Applications at Scale

Stratasys Ltd. (NASDAQ: SSYS) announced the launch of the new F870 FDM system, a large-format additive manufacturing platform designed for industrial manufacturers, automotive OEMs, aerospace & defense production lines, looking to scale production on the factory floor.This press release features...

Stratasys and Limbitless Solutions Expand Ongoing Partnership Providing Access to 3D-Printed Prosthetics for Children

Stratasys Ltd. (NASDAQ: SSYS), a global leader in additive manufacturing solutions, and Limbitless Solutions, a nonprofit research facility at the University of Central Florida dedicated to empowering children through bionics, today announced the expansion of a 12-year collaboration that has...

Stratasys Q2 Earnings Beat, Revenues Miss on Weak System Sales

SSYS beats Q2 earnings estimates as record consumables revenues and aerospace growth offset weaker system sales and currency pressure.


Stratasys Ltd. engages in the development of industrial grade additive solutions. It offers three-dimensional printers and parts, materials, and software. The company was founded on March 3, 1998 and is headquartered in Minnetonka, MN.

Stratasys Ltd

Stratasys Stock Declines Pre-Market As 2025 Guidance Fails To Meet Wall Street Expectations: Retail’s On The Fence

Equity

Bearish Sentiment

Shares of Stratasys Inc. (SSYS) declined over 3% in Wednesday’s pre-market session after the company’s 2025 <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.stratasys.com/news-events/press-releases/detail/934/stratasys-releases-fourth-quarter-and-full-year-2024">guidance</a> fell short of Wall Street's expectations.Revenue declined 4% year over year (YoY) to $150.36 million but beat a Wall Street estimate of $149.97 million, per Koyfin data. The company reported adjusted earnings per share (EPS) of $0.12, marginally topping an analyst estimate of $0.10.For 2025, Stratasys expects revenue of $570 million to $585 million, lower than a Street estimate of $585.86 million. The company projected an adjusted EPS of $0.28 to $0.35 versus a Street estimate of $0.36.The company also guided for adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) of $44 million to $50 million, reflecting an adjusted EBITDA margin of 7.8% to 8.5%. Capital expenditures are expected to be $25 million to $30 million.CEO Yoav Zeif said that continuing strong customer engagement reaffirmed the company’s expectations that once spending constraints ease, adoption rates will accelerate, and the firm will return to growth and generate increased profits.“Our healthy balance sheet of $150.7 million in cash, cash equivalents, and short-term deposits, with no debt, provides stability and optionality to support our growth. We look forward to closing the $120 million investment from Fortissimo Capital that will further bolster our already robust position to help drive our future growth,” he said.On Stocktwits, retail sentiment continued to trend in the ‘neutral’ territory on Wednesday morning.<figure class="image"><img style="aspect-ratio:1854/428;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_05_at_8_37_29_AM_937cdc7159.png" alt="SSYS’s Sentiment Meter and Message Volume as of 8:14 a.m. ET on March 5, 2025 | Source: Stocktwits" width="1854" height="428"><figcaption>SSYS’s Sentiment Meter and Message Volume as of 8:14 a.m. ET on March 5, 2025 | Source: Stocktwits</figcaption></figure>Recently, Cantor Fitzgerald raised its price target on Stratasys to $15 from $12 while keeping an ‘Overweight’ rating ahead of the Q4 results, according to TheFly.<a href="https://stocktwits.com/symbol/SSYS">SSYS stock</a> has gained 22% in 2025 but lost over 9% over the past year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/kkr-to-sell-stake-in-japanese-supermarket-chain-seiyu-to-trial-holdings/cheZABiR6I">KKR To Sell Stake In Japanese Supermarket Chain Seiyu To Trial Holdings: Retail Optimism Rises</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The booth of Stratasys seen at Robotworld 2022 held at Kintex in Goyang City, Gyeonggi Province. (Photo by Simon Shin/SOPA Images/LightRocket via Getty Images)

For 2025, Stratasys expects revenue of $570 million to $585 million, lower than a Street estimate of $585.86 million. The company projected an adjusted EPS of $0.28 to $0.35 versus an analyst estimate of $0.36.

Buying the dip

Selling or trimming

Holding

Waiting for the investigation results to decide

Nvidia ($NVDA) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Stocktwits

) is down about 4% after its board opened an investigation into CEO Jensen Huang. What are you doing with the stock?

Current Price	$6.73
Prev Close	$6.42
Open	$6.43
Dividend Yield	0.00%
50-Day Moving Average	$7.58
Beta	1.45
Avg. Volume	760,533.90
PE Ratio	-4.78

52-Week High	$12.24
52-Week Low	$6.08
Market Capitalization	$565.49M
EPS (Annual)	-$1.28
Price to Book	0.69
Revenue Per Employee	$313,664.77

Feed

News

Sentiment

Earnings

Fundamentals

Info

SSYS Fundamentals